These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10576040)

  • 1. Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1999 Nov; 31(7A):31S-33S. PubMed ID: 10576040
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft versus host antibody reactions in ABO unmatched renal transplants.
    Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Tosi P; Bandini S; Salvadori M
    Transplant Proc; 1998 Aug; 30(5):2304-5. PubMed ID: 9723483
    [No Abstract]   [Full Text] [Related]  

  • 3. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
    Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
    Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of immunosuppressive induction regimens in renal transplantation. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Dec; 30(8):4029-30. PubMed ID: 9865286
    [No Abstract]   [Full Text] [Related]  

  • 5. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
    Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
    Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
    [No Abstract]   [Full Text] [Related]  

  • 6. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance immunosuppressive treatment and graft half-life.
    Cai J; Gjertson DW; Terasaki P
    Clin Transpl; 2002; ():359-66. PubMed ID: 12971462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation in Singapore.
    Vathsala A; Lee WT; Li MK; Woo KT; Lim CH
    Transplant Proc; 1995 Feb; 27(1):1472-5. PubMed ID: 7878947
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J; Ortuño J;
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative induction therapy with oral cyclosporine for recipients of living-related renal transplants.
    Rudich SM; Bhaduri S; Chang T; Cahn J; Katznelson S; Perez RV
    Transplant Proc; 1998 Jun; 30(4):1339-42. PubMed ID: 9636545
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
    Claesson K; Mayer AD; Squifflet JP; Grabensee B; Eigler FW; Behrend M; Vanrenterghem Y; van Hooff J; Morales JM; Johnson RW; Buchholz B; Land W; Forsythe JL; Neumayer HH; Ericzon BG; Mühlbacher F
    Transplant Proc; 1998 Jun; 30(4):1292-4. PubMed ID: 9636524
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine: has it made a difference between using HLA or not? A comparative study between patients with and without HLA matching.
    Juarez F; Barrios Y; Cano L; Chavez E; Camacho R; Gomez A; Maciel M; Borjon S; Limones M; Peniche L
    Transplant Proc; 1998 Aug; 30(5):1744-5. PubMed ID: 9723263
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term graft survival of living-related kidneys after donor-specific transfusion.
    Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Fukunaga K; Seino K; Todoroki T; Fukao K
    Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.